Smart jab can shrink head and neck cancer tumours within six weeks, trial finds
Triple-action therapy drug amivantamab could be given as an injection to help treat recurrent or metastatic cancers Doctors have hailed “incredibly encouraging” trial results that show a triple-action smart jab can shrink tumours in head and neck cancer patients within six weeks. Head and neck (…)
Site référencé:
The Guardian (South&CentralAsia)
3566.jpg?width=140&quality=85&auto=format&fit=max&s=6b8d8aa1d243e52630ec912240d7c64f, 3566.jpg?width=460&quality=85&auto=format&fit=max&s=2d87713509e54a6825bcd7efa979683a, 3566.jpg?width=700&quality=85&auto=format&fit=max&s=0f55e3e23cd4fdddf1f92afd52d64c83
The Guardian (South&CentralAsia)
Reform council leader says she has launched hunt for ‘cowards’ behind leaked video
19/10/2025
Manchester United end wait for Anfield win as Maguire header stuns Liverpool
19/10/2025
The Guardian view on hybrid cars : profitable for carmakers but not very green | Editorial
19/10/2025
The Guardian view on childbirth and medical negligence : rising payouts highlight the urgency of maternity improvements
19/10/2025
Ella Baron on Prince Andrew’s fall from grace – cartoon
19/10/2025
Chinese embassy approval could be unlawful if UK ministers gave advance assurances
19/10/2025